Related references
Note: Only part of the references are listed.Influence of PD-L1 cross-linking on cell death in PD-L1-expressing cell lines and bovine lymphocytes
Ryoyo Ikebuchi et al.
IMMUNOLOGY (2014)
Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer
Mario Sznol et al.
CLINICAL CANCER RESEARCH (2013)
Enhanced expression of LAG-3 on lymphocyte subpopulations from persistently lymphocytotic cattle infected with bovine leukemia virus
Satoru Konnai et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2013)
Blockade of bovine PD-1 increases T cell function and inhibits bovine leukemia virus expression in B cells in vitro
Ryoyo Ikebuchi et al.
VETERINARY RESEARCH (2013)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Increased bovine Tim-3 and its ligand expressions during bovine leukemia virus infection
Tomohiro Okagawa et al.
VETERINARY RESEARCH (2012)
PD-1 and PD-L1 upregulation promotes CD8+ T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients
Feng Shi et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Progressive Upregulation of PD-1 in Primary and Metastatic Melanomas Associated with Blunted TCR Signaling in Infiltrating T Lymphocytes
Maxime Chapon et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Molecular cloning of bovine lymphocyte activation gene-3 and its expression characteristics in bovine leukemia virus-infected cattle
Tatsuya Shirai et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2011)
Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade
Ryoyo Ikebuchi et al.
VETERINARY RESEARCH (2011)
Methods and mortality results of a health survey of purebred dogs in the UK
V. J. Adams et al.
JOURNAL OF SMALL ANIMAL PRACTICE (2010)
Interaction of B7-H1 on Intrahepatic Cholangiocarcinoma Cells With PD-1 on Tumor-Infiltrating T Cells as a Mechanism of Immune Evasion
Yufu Ye et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
B7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progression
Lei Geng et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment
Monika M. Welle et al.
VETERINARY DERMATOLOGY (2008)
Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs
Raymond M. Wong et al.
INTERNATIONAL IMMUNOLOGY (2007)
PD-L1 (B7-H1) expression by urothelial carcinoma of bladder and BCG-induced granulomata - Associations with localized stage progression
Brant A. Inman et al.
CANCER (2007)
Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer
Takeo Nomi et al.
CLINICAL CANCER RESEARCH (2007)
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up
RH Thompson et al.
CANCER RESEARCH (2006)
The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia
WL Spangler et al.
VETERINARY PATHOLOGY (2006)
The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: Correlation with important high-risk prognostic factors
Hazem Ghebeh et al.
NEOPLASIA (2006)
Mast cells enhance T cell activation: Importance of mast cell costimulatory molecules and secreted TNF
S Nakae et al.
JOURNAL OF IMMUNOLOGY (2006)
Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-γ-induced upregulation of B7-H1 (CD274)
SJ Lee et al.
FEBS LETTERS (2006)
Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance
Changping Wu et al.
ACTA HISTOCHEMICA (2006)
Renal tubular epithelial cells modulate T-cell responses via ICOS-L and B7-H1
S de Haij et al.
KIDNEY INTERNATIONAL (2005)
Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs
PA Boria et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2004)
PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3ζ signalosome and downstream signaling to PKCθ
KA Sheppard et al.
FEBS LETTERS (2004)
B7-h1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression
J Konishi et al.
CLINICAL CANCER RESEARCH (2004)
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation
JM Chemnitz et al.
JOURNAL OF IMMUNOLOGY (2004)
A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation
DR Proulx et al.
VETERINARY RADIOLOGY & ULTRASOUND (2003)
Effect of natural and synthetic retinoids on the proliferation and differentiation of three canine melanoma cell lines
E Ohashi et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2002)
Establishment and characterization of a new canine mast cell tumor cell line
T Ishiguro et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2001)
IgG-mediated histamine release from canine mastocytoma-derived cells
T Takahashi et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2001)
Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989-2000)
KM Rassnick et al.
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2001)
Effect of retinoids on growth inhibition of two canine melanoma cell lines
E Ohashi et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2001)